Latest News and Press Releases
Want to stay updated on the latest news?
-
BioXcel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Operational Highlights
Commercially launched IGALMI™ (dexmedetomidine) sublingual film for the acute treatment of agitation in bipolar I or II disorder and schizophrenia in adult patients SERENITY III pivotal...
-
Company to host conference call today at 8:00 AM Eastern NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and...
-
NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Kaltura, Inc. (“Kaltura” or the “Company”), the video experience cloud, today announced financial results for the second quarter ended June 30, 2022, as...
-
Announced FDA acceptance of FUROSCIX® New Drug Application and Prescription Drug User-Fee Act target action date of October 8, 2022 Continued to advance commercial readiness activities in support of...
-
SHANGHAI, China, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun" or the "Company"), the leading brand e-commerce service partner that helps brands execute their...
-
New York, NY, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The Regenerative Engineering Society (RE Society) — a technical entity of the American Institute of Chemical Engineers (AIChE) — is celebrating the...
-
Cambridge, Massachusetts, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The math and reading achievement of U. S. students has been rising for half a century with Black, Hispanic, and Asian students showing...
-
VANCOUVER, British Columbia, Aug. 09, 2022 (GLOBE NEWSWIRE) -- AIP Realty Trust (the “Trust” or “AIP Realty”) (TSXV:AIP.U) today announced that its exclusive development and property management...
-
Los Angeles , Aug. 09, 2022 (GLOBE NEWSWIRE) -- Famed TikTok creative and rapper Carl Dawson, also known as KingCarlX, partnered with the 501(c)(3) nonprofit Christy’s Foundation to offer support to...
-
Company to host a webcast today at 4:30 p.m. Eastern Time NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage...